Medicine and Dentistry
Prostate Cancer
100%
Hypofractionated Radiotherapy
85%
Acute Toxicity
72%
Urinary System
36%
Radiation Therapy
33%
Prospective Cohort Study
33%
Quality of Life
22%
Patient-Reported Outcome
20%
Systematic Review
16%
Meta-Analysis
16%
Randomized Controlled Trial
16%
Observational Study
16%
Gastrointestinal Distress
14%
Health Care Cost
11%
Bladder
11%
Deterioration
9%
Logistic Regression Analysis
8%
Diseases
8%
Symptom Management
8%
Lower Urinary Tract Symptom
6%
Diarrhea
6%
Oncology
6%
Attributable Risk
5%
Gastrointestinal Toxicity
5%
Arm
5%
Clinical Management
5%
Prospective Study
5%
Rectal Bleeding
5%
Mucus
5%
Patient Experience
5%
Toxicity Assessment
5%
Androgen Deprivation Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
83%
Acute Toxicity
55%
Prospective Cohort Study
33%
Randomized Controlled Trial
16%
Observational Study
16%
Deterioration
16%
Gastrointestinal Symptom
14%
Diseases
10%
Androgen
7%
Lower Urinary Tract Symptom
6%
Diarrhea
6%
Prospective Study
5%
Gastrointestinal Toxicity
5%
Painful Defecation
5%
Rectum Hemorrhage
5%
Toxicity Assessment
5%
